Effect of experimental hookworm infection on insulin resistance in people at risk of Type 2 Diabetes: a randomized, placebo-controlled trial
Pierce, D.; McDonald, M.; Merone, L.; Becker, L.; Thompson, F.; Lewis, C.; Field, M.; Rahman, T.; Croese, J.; Loukas, A.; McDermott, R.; Giacomin, P.
Show abstract
The reduced prevalence of insulin resistance and type 2 diabetes (T2D) in countries with endemic parasitic worm infections suggests a protective role for worms against metabolic disorders, however clinical evidence has been non-existent. This 2-year randomized controlled trial of hookworm infection in 40 people at risk of T2D involved treatment with either 20 or 40 Necator americanus third-stage larvae (L3) or Placebo. Primary outcome was safety, with homeostatic model assessment of insulin resistance (HOMA-IR), fasting blood glucose (FBG), and body mass being the key metabolic outcomes. Adverse events were more frequent in hookworm-treated participants, where 44% experienced transient gastrointestinal symptoms. FBG and HOMA-IR were significantly lowered in both hookworm-treated groups at 1-year, and body mass was significantly lowered after L3-20 treatment at 2-years. Overall, hookworm infection was well tolerated in people at risk of T2D, and were associated with improved insulin resistance, warranting further exploration of the benefits of hookworms on metabolic health.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Impact of intestinal parasitic infections on gut epithelial barrier and inflammation among foreign-born persons living with HIV 92%
- Comparing azithromycin to amoxicillin in the management of uncomplicated severe acute malnutrition in Burkina Faso: a pilot randomized trial 91%
- Early-life enteric infection and enteropathy markers are associated with changes in adipokine, apolipoprotein and cytokine profiles later in childhood consistent with those of an adverse cardiometabolic disease risk profile in a Peruvian birth cohort 90%
Similar papers in this journal
- Nuclear magnetic resonance-based metabolomics with machine learning for predicting progression from prediabetes to diabetes 91%
- Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice 90%
- A hepatocyte-specific transcriptional program driven by Rela and Stat3 exacerbates experimental colitis in mice by modulating bile synthesis 90%
Similar papers in this journal
- The effects of time-restricted eating vs. standard dietary advice on weight, metabolic health and the consumption of processed food: A pragmatic randomised controlled trial in community-based adults 92%
- Are probiotics and prebiotics safe for use during pregnancy and lactation? A systematic review and meta-analysis 92%
- Multi-strain fermented milk promotes gut microbiota recovery after Helicobacter pylori therapy: a randomised, controlled trial 92%
Similar papers in this journal
- Predictive value of circulating NMR metabolic biomarkers for type 2 diabetes risk in the UK Biobank study 91%
- The Incidence of Immune Mediated Inflammatory Diseases Following COVID-19: a Matched Cohort Study in UK Primary Care 91%
- Helicobacter pylori seropositivity associates with hyperglycemia, but not obesity in Danish children and adolescents 91%
Similar papers in this journal
- A Standardized Metric to Enhance Clinical Trial Design and Outcome Interpretation in Type 1 Diabetes 93%
- Gut microbial communities modulate efficacy of albendazole-ivermectin against soil-transmitted helminthiases 92%
- Lysates of Methylococcus capsulatus Bath induce a lean-like microbiota, intestinal FoxP3+RORγt+IL-17+ Tregs and improve metabolism 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.